Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Neovasc stock

Own Neovasc stock in just a few minutes.

Posted

Fact checked

Neovasc Inc is a medical devices business based in the US. Neovasc shares (NVCN) are listed on the NASDAQ and all prices are listed in US Dollars. Neovasc employs 110 staff and has a trailing 12-month revenue of around USD$2 million.

How to buy shares in Neovasc

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Neovasc. Find the stock by name or ticker symbol: NVCN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Neovasc reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Neovasc, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Neovasc. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Neovasc share price

Use our graph to track the performance of NVCN stocks over time.

Neovasc shares at a glance

Information last updated 2020-11-26.
52-week range USD$0.71 - USD$4.17
50-day moving average USD$1.5022
200-day moving average USD$2.198
Wall St. target price USD$1.88
PE ratio 0.1182
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-5.638

Buy Neovasc shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Neovasc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Neovasc under- or over-valued?

Valuing Neovasc stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Neovasc's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Neovasc's P/E ratio

Neovasc's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Neovasc shares trade at around 0x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Neovasc financials

Revenue TTM USD$2 million
Gross profit TTM USD$1.6 million
Return on assets TTM -130.67%
Return on equity TTM 0%
Profit margin 0%
Book value $0.029
Market capitalisation USD$18.8 million

TTM: trailing 12 months

Shorting Neovasc shares

There are currently 168,259 Neovasc shares held short by investors – that's known as Neovasc's "short interest". This figure is 140.2% up from 70,063 last month.

There are a few different ways that this level of interest in shorting Neovasc shares can be evaluated.

Neovasc's "short interest ratio" (SIR)

Neovasc's "short interest ratio" (SIR) is the quantity of Neovasc shares currently shorted divided by the average quantity of Neovasc shares traded daily (recently around 701079.16666667). Neovasc's SIR currently stands at 0.24. In other words for every 100,000 Neovasc shares traded daily on the market, roughly 240 shares are currently held short.

However Neovasc's short interest can also be evaluated against the total number of Neovasc shares, or, against the total number of tradable Neovasc shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Neovasc's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Neovasc shares in existence, roughly 10 shares are currently held short) or 0.0075% of the tradable shares (for every 100,000 tradable Neovasc shares, roughly 8 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Neovasc.

Find out more about how you can short Neovasc stock.

Neovasc share dividends

We're not expecting Neovasc to pay a dividend over the next 12 months.

Have Neovasc's shares ever split?

Neovasc's shares were split on a 1:10 basis on 2 July 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Neovasc shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Neovasc shares which in turn could have impacted Neovasc's share price.

Neovasc share price volatility

Over the last 12 months, Neovasc's shares have ranged in value from as little as $0.71 up to $4.17. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Neovasc's is 3.2509. This would suggest that Neovasc's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Neovasc overview

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets medical devices for cardiovascular marketplace in Europe, the United States, and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site